Xconomy Boston

Concert Pharmaceuticals Garners $37,000,000 Series C Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=99d7c5fd-86fd-429f-8441-833564ee286a&Preview=1
Date
4/30/2008
Company Name
Concert Pharmaceuticals
Mailing Address
99 Hayden Avenue Lexington, MA 02421
Company Description
Concert Pharmaceuticals, a privately held pharmaceutical company, is focused on developing novel small molecule drugs for unmet medical needs. Concert utilizes its advanced methodology to rapidly create potent bioavailable drug candidates.
Website
http://www.concertpharma.com/
Transaction Type
Venture Equity
Transaction Amount
$37,000,000
Transaction Round
Series C
Proceeds Purposes
The Company intends to use the proceeds to further advance its deuterium chemistry platform and product pipeline.
M&A Terms
Venture Investor
Undisclosed
Venture Investor
Adage Capital Management
Venture Investor
Three Arch Partners
Venture Investor
TVM Capital
Venture Investor
Skyline Ventures
Venture Investor
Flagship Ventures
Venture Investor
Brookside Capital
Venture Investor
Greylock Partners
Venture Investor
New Leaf Venture Partners
Venture Investor
QVT Fund LP